Optimizing Treatment on Idiopathic Inflammatory Myopathies

Recruiting now

Conditions studied: Idiopathic Inflammatory Myopathies

In brief

As a T2T, our patients with idiopathic inflammatory myopathies will receive pulse therapies with methyprednisolone and/or human intravenous immunoglobulin, or only methyprednisolone at disease onset. This scheme is an internal routine protocol of our Service.

Key facts

Study ID

NCT03092180

Run by

University of Sao Paulo

People needed

60

Starts

2005-01-01

Expected to finish

2024-12-04

Last updated by the study team

2024-12-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Idiopathic inflammatory myopathies

You may not qualify if…

• Inclusion body myositis, muscular dystrophies, neoplasia-associated myopathies, overlapped myopathies, others myopathies

Where it is running

• Samuel Katsuyuki Shinjo — São Paulo, Brazil (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.